Prepare to be mind blown in this episode as CEO Anthony Tennyson and professor David Nutt of Awakn Life Sciences, sit down with the StockFam for an enlightening conversation regarding their ground-breaking ketamine and MDMA therapeutics. Their unique business model coupled with their proven results of treating various forms of disorders and addiction are the factors that set Awakn apart from any other biotech company in the world.
https://linktr.ee/stockfam
https://discord.com/invite/B7CEn5xBce
